Traction-assisted endoscopic submucosal dissection to resect ileo-cecal valve neoplasia: a French retrospective multicenter case series

Clara Yzet,Timothee Wallenhorst,Jeremie Jacques,Mariana Figueiredo Ferreira,Jérôme Rivory,Florian Rostain,Louis Jean Masgnaux,Jean Grimaldi,Romain Legros,Pierre Lafeuille,Jérémie Albouys,Fabien Subtil,Marion Schaefer,Mathieu Pioche
DOI: https://doi.org/10.1055/a-2316-4910
2024-04-29
Endoscopy
Abstract:Introduction: The ileocecal valve (ICV) is considered to be one of the most difficult locations for endoscopic submucosal dissection (ESD). The objective of this study was to evaluate the efficacy and safety of traction-assisted ESD in this situation. Methods: All patients who underwent traction assisted ESD for an ICV lesion were identified from a prospective ESD database in three centers. The results were evaluated in terms of en bloc, R0 rate. Factors associated with R0 failure were explored. Results: In total, 106 patients with an ileocecal lesion were included. The median diameter of the lesions was 50 mm (IQR 38-60) and 58.4% (62/106) invaded the terminal ileum. The en-bloc and R0 resection rates were 94.8% and 76.4%, respectively. Factors associated with R0 failure were lesions covering more than 75% of the ICV (OR, 0.21 [0.06, 0.76] p = 0.018), anal lip involvement (OR 0.36 [0.13, 0.99], p= 0.037), and more than two sites of the ICV (OR 0.28 [0.08, 1.01] p = 0.030). Conclusion: Traction-assisted ESD to treat ICV lesions is a safe and feasible option. Large lesions and anal lip involvement appear to be factors predictive of difficulty.
gastroenterology & hepatology,surgery
What problem does this paper attempt to address?